Sector · Margin Call
Biotech & Gene Therapy
Biotech companies developing gene editing (CRISPR), mRNA, cell therapy, and gene therapies. A high-volatility sector where stock prices react sharply to clinical trial events.
Biotech companies developing gene editing (CRISPR), mRNA, cell therapy, and gene therapies. A high-volatility sector where stock prices react sharply to clinical trial events.